Core Viewpoint - The company plans to utilize up to 2.1 billion yuan of temporarily idle raised funds for cash management, focusing on safe and liquid principal-protected products [1] Group 1: Cash Management Plan - The company will purchase various financial products, including but not limited to agreement deposits, structured deposits, time deposits, notice deposits, and large-denomination certificates of deposit [1] - The approved cash management plan is valid for 12 months from the date of the board's approval [1] - The company emphasizes that this cash management will not affect the progress of investment projects funded by the raised funds or its normal production and operations [1] Group 2: Use of Proceeds - The income generated from this cash management will be prioritized for supplementing any shortfall in investment projects and for replenishing working capital [1] - The proceeds will be returned to the designated raised funds account as per regulations [1]
禾元生物：拟使用不超21亿元闲置募集资金进行现金管理